Transitioning to prostate cancer, FMRP’s regulatory scope expands to metabolic processes, where it collaborates with circRBM33 to stabilize PDHA1 mRNA, thereby boosting ATP production and supporting the metabolic adaptation critical for tumor survival [105]. Here, FMR1 is linked to neoplasm.